The table below shows Taysha Gene Therapies, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$9.77M
$8.33M
$15.45M
$2.50M
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$86.40M
$66.00M
$56.78M
$91.17M
$131.94M
$31.89M
SG&A
$33.87M
TSHA annual revenue (10-K history)
Taysha Gene Therapies, Inc. reported annual revenue of $9.77M for fiscal year 2025. That is up 17.3% from $8.33M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.